Close
RNS Number : 6858R
Animalcare Group PLC
08 November 2021
 

Animalcare Group plc

 

(The "Company" or the "Group")

 

Grant of options

 

8 November 2021. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 5 November 2021, nil-cost options over a total of 264,981 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to 
the Executive Directors and PDMRs of the Company and to members of the Senior Executive
Team pursuant to the Company's Long Term Incentive Plan.

 

The awards will normally vest on 31 December 2024 following the assessment of performance criteria based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) over a three-year financial period ending 31 December 2024 and are as follows:

 

Earnings Per Share growth per annum

Extent to which EPS tranche will vest

Less than 3%

0%

3%

25%

10%

100%

Between 3% and 10%

Between 25% and 100% on a straight line basis

 

Rank of the Company's TSR compared to the Comparator Group

Extent to which the TSR tranche will vest

Upper quartile or above

100%

Between median and upper quartile

Pro rata between 25% and 100% on a ranking basis

Median

25%

Below median

0%

 

50% of the option award will be subject to the EPS performance condition and the remaining 50% 
will be subject to the TSR performance condition. Accordingly, if one of the performance conditions 
is met but the other is not, the Option award will only vest in part.

 

After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:

 

PDMR

Options Awarded

Total Options

Ordinary Shares

Jennifer Winter

       106,844

 

450,175

 

0

Chris Brewster

         43,806

 

187,290

 

280,513

Options over a further 114,331 ordinary shares were granted to other members of the Senior Executive Team.

 

The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:

 

 

 

ANNEX

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Jennifer Winter, Chief Executive Officer

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1(a) above - Ms Winter is classified as a PDMR of the Company

 

b)

 

Initial notification

/Amendment

 

Initial Notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Animalcare Group plc

 

b)

 

LEI

 

213800A7XPQ528RMCC72

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

 

b)

 

Identification code

 

GB0032350695

 

c)

 

Nature of the transaction(s)

Award of options

 

d)

 

Price(s) and volume(s)

 

Volume(s):

 

Nil cost options over 106,844 shares

Price:

£Nil

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

f)

 

Date of the transaction

 

5 November 2021

 

g)

 

Place of the transaction

 

Outside a trading venue

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Chris Brewster, Chief Financial Officer

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1(a) above - Mr Brewster is classified as a PDMR of the Company

 

b)

 

Initial notification

/Amendment

 

Initial Notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Animalcare Group plc

 

b)

 

LEI

 

213800A7XPQ528RMCC72

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

 

b)

 

Identification code

 

GB0032350695

 

c)

 

Nature of the transaction(s)

Award of options

 

d)

 

Price(s) and volume(s)

 

Volume(s):

 

Nil cost options over 43,806 shares Price:

£Nil

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

f)

 

Date of the transaction

 

  5 November 2021

 

g)

 

Place of the transaction

 

Outside a trading venue

 

 

For more information about Animalcare, please visit www.animalcaregroup.com or contact:

 

Animalcare Group plc

Jenny Winter, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Media relations

 

+44 (0)1904 487 687

 

 

communications@animalcaregroup.com

 

Stifel Nicolaus Europe Limited
 (Nominated Adviser & Joint Broker)

Ben Maddison

Fred Walsh

Nick Adams

 

+44 (0)20 7710 7600

Panmure Gordon

(Joint Broker)

Corporate Finance

Freddy Crossley/Emma Earl

Corporate Broking

Rupert Dearden

 

+44 (0)20 7886 2500

 

About Animalcare

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries - Spain, Portugal, Italy, UK, Germany, Belgium and Netherlands - and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXBDBXDGDGBI